Home / Import refusals / NUV-3881703-0/10002/1

FDA Import Refusal NUV-3881703-0/10002/1 — Bristol-Myers Squibb Company

Bristol-Myers Squibb Company — FEI 3008455069

The FDA refused shipment NUV-3881703-0/10002/1 from Bristol-Myers Squibb Company (United States) on February 24, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 118 This firm has 5 or more other import refusals on record.

Refusal Details

Date
February 24, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCP72 SEMAGLUTIDE (ANTI-DIABETIC)
Charges
118

Recent inspections

  • 1272436 (VAI Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115960 (VAI Fri Jan 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008167 (VAI Wed Apr 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 932048 (NAI Fri Jun 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 836877 (VAI Thu Jun 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • N4H-0007545-4/10001/2 (Tue Apr 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/60002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/20002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/40002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3881703-0/30002/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources